eCite Digital Repository

Arsenic exposure via drinking water adversely affects lung health


Ramsey, KA and Sly, PD and Larcombe, AN and Zosky, GR, Arsenic exposure via drinking water adversely affects lung health, Respirology, 15-17 August, 2012, Queenstown, New Zealand, pp. 25. ISSN 1323-7799 (2012) [Conference Extract]

Pending copyright assessment - Request a copy

DOI: doi:10.1111/j.1440-1843.2012.02142.x


Introduction: The contamination of drinking water with arsenic is a global health problem. Early life exposure to arsenic increases the risk of lower respiratory tract infections during infancy and increases the risk of mortality from bronchiectasis in adulthood. We aimed to characterize the effect of arsenic exposure via drinking water on lung development and responses to early life viral infection.

Methods: C57BL/6 mice were exposed to 100 μg/L arsenic in prenatal and postnatal life with or without influenza infection. Somatic growth, lung structure, lung function and airway hyperresponsiveness were measured using stereology, plethysmography and the forced oscillation technique. Differential gene expression was determined by microarray and confirmed with qRT-PCR.

Results: Mice exposed to arsenic in early life were smaller, had smaller lungs and impaired lung function. Early life exposure to arsenic altered the expression of genes that function in innate immunity (Lplunc1, Reg3γ), lung morphogenesis (Sox2) and airway mucous regulation (mClca3, Muc5b). Upregulation of mClca3 corresponded to mucous cell metaplasia. Adult mice that were exposed to arsenic early in life had increased airway smooth muscle and airways that were hyperresponsive to methacholine, while mice exposed to arsenic for the same period of time in adulthood were not affected. Arsenic exposure increased the acute inflammatory response to early life influenza infection and had additive effects on long term lung function impairment and airway hyperresponsiveness.

Conclusions: Arsenic is a potent developmental toxicant that adversely affects the lung by altering lung structure, mucous expression, innate immunity, responses to bronchoconstricting agents and exacerbating respiratory viral infection.

Item Details

Item Type:Conference Extract
Keywords:lung disease
Research Division:Biomedical and Clinical Sciences
Research Group:Cardiovascular medicine and haematology
Research Field:Respiratory diseases
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Zosky, GR (Professor Graeme Zosky)
ID Code:97228
Year Published:2012
Deposited By:Medicine
Deposited On:2014-12-08
Last Modified:2022-06-29

Repository Staff Only: item control page